lunes, 16 de noviembre de 2026
FDA Approves First Drug to Treat Adults with Primary Membranous Nephropathy
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-drug-treat-adults-primary-membranous-nephropathy?utm_medium=email&utm_source=govdelivery
The U.S. Food and Drug Administration has approved Gazyva (obinutuzumab) injection to treat adults with primary membranous nephropathy at risk of disease progression, to induce remission of proteinuria (protein in the urine). This is the first drug approved specifically for the treatment of adults with primary membranous nephropathy.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario